5Allison DB. Antipsychotic-ind ueed weight gain:a comprehensive research synthesis[J]. Am J Psychiatry, 1999,156(11):1686-1689.
6Daniel DG, Goldberg TE, Weinberger DR. Different side effect profile of risperidone and clozapine in 20 outpatients with schzophrenia or schzoaffective disorder: a pilot study[J], Am J Psychiatry, 1996,15;3(3) ;417.
7Collaborative working group on clinical trial evaluations.Adverse effects of the atypical antipsychotics [J]. J Clin Psychiatry,1998,59(Suppl 12) :12- 20.
8Gary R, D2 and 5-HT2 receptor effects of antipsychotics:bridging basic and clinical findings using PET[J]. J Chin Psychiatry ,1999,60(Suppl 10):15-23.
9Harrison PJ. Neuroechemical alteration in schizophrenia affecting the putative receptor target of atypical antipsychotic: focus on dopamine ( D1 , D3,D4) and 5-HT2A receptor [J]. Br J Psychiatry. 1999,174 ( Suppl 38) : 12- 22.
10Kerwin R,Owen M. Genetics of novel therapeutic targets in schizophrenia[J]. Br J Psychiatry, 1999,174( Suppl 38) : 1 -4.
